China Pharma Holdings Inc (CPHI)

Currency in USD
1.4850
-0.0600(-3.88%)
Closed·
After Hours
1.4799-0.0051(-0.34%)
·
CPHI Scorecard
Full Analysis
Operates with a significant debt burden
Unusual trading volume
CPHI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.41901.6600
52 wk Range
1.20003.3500
Key Statistics
Prev. Close
1.545
Open
1.58
Day's Range
1.419-1.66
52 wk Range
1.2-3.35
Volume
336.14K
Average Volume (3m)
112.44K
1-Year Change
-17.04%
Book Value / Share
2.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CPHI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
May have trouble making interest payments on debt

China Pharma Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

China Pharma Holdings Inc Company Profile

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection for edema diseases, hypertension, acute renal failure, hyperkalemia, hypercalcemia, and acute drug poisoning; and Candesartan for hypertension. It offers Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and Pseudophedrine Hydrochlorida sustained release tablets. It offers Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection for nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies. The company is based in Haikou, the People’s Republic of China.

Employees
224

Compare CPHI to Peers and Sector

Metrics to compare
CPHI
Peers
Sector
Relationship
P/E Ratio
−1.1x−31.0x−0.5x
PEG Ratio
−0.020.000.00
Price/Book
0.7x5.9x2.6x
Price / LTM Sales
1.1x3.5x3.3x
Upside (Analyst Target)
-149.8%43.4%
Fair Value Upside
Unlock14.2%7.1%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.24 / --
Revenue / Forecast
1.14M / --
EPS Revisions
Last 90 days

CPHI Income Statement

People Also Watch

247.45
AVAV
-4.68%
22.550
METC
+4.06%
5.4000
ATHE
+1.69%
0.675
MBRX
-0.44%
60.87
TEM
+3.63%

FAQ

What Stock Exchange Does China Pharma Trade On?

China Pharma is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for China Pharma?

The stock symbol for China Pharma is "CPHI."

What Is the China Pharma Market Cap?

As of today, China Pharma market cap is 4.84M.

What Is China Pharma's Earnings Per Share (TTM)?

The China Pharma EPS (TTM) is -2.05.

From a Technical Analysis Perspective, Is CPHI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has China Pharma Stock Split?

China Pharma has split 3 times.

How Many Employees Does China Pharma Have?

China Pharma has 224 employees.

What is the current trading status of China Pharma (CPHI)?

As of 10 Aug 2025, China Pharma (CPHI) is trading at a price of 1.49, with a previous close of 1.55. The stock has fluctuated within a day range of 1.42 to 1.66, while its 52-week range spans from 1.20 to 3.35.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.